Navigation Links
World's First Cervical Cancer Vaccine to go on Sale

The world's first and only cervical cancer vaccine, Gardasil, which has proved effective against the virus that causes most cervical cancers, may go on sale within weeks, the company //marketing it said.

The vaccine developed by US pharmaceutical company Merck & Co. Inc. has proved 100 percent effective against the two main strains of the Human Papilloma Virus (HPV) which trigger most cervical cancers, reported the online edition of Daily Mail.

The US Food and Drug Administration (FDA) approved this vaccine last month.

Sanofi Pasteur MSD, the European company which is marketing Gardasil, received a "positive opinion" from the Committee for Medicinal Products for Human Use just seven months after applying for a licence.

The European Commission is now expected to grant an authorisation for marketing it by September - at least three months ahead of schedule.

Cervical cancer kills nearly 4,000 women in the US annually and nearly 300,000 worldwide, according to the National Cervical Cancer Coalition.

Gardasil protects against four HPV strains, as well as a number of conditions caused by the virus, including genital warts.

The cost of the vaccine has not yet been decided. Analysts believe it could cost 60 pounds per dose, with patients needing three treatments.

Another cervical cancer vaccine, called Cervarix, made by GlaxoSmithKline, is still going through the licensing process.

It was submitted for a licence in March and could take another three months to reach the same stage as Gardasil.

(Source: IANS)
'"/>




Page: 1

Related medicine news :

1. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
2. Worlds oldest turns 116 in Japan
3. Indian Doctor in Worlds 65 caring doctors
4. Worlds Smallest Fish Found In Indonesia
5. Italian Doctors To Operate On Worlds Fattest Man
6. Worlds 3 out of 10 Cigarettes Smoked in China
7. Diabetes Labeled As Worlds Fifth Killer Disease
8. Scientists Trace the Roots of the Worlds Healthiest Wines
9. Worlds Oldest Mother Admits Her Actual Age
10. The Worlds First Digital Insulin Pen With a Memory Launched
11. Worlds Oldest High-wire Artiste Hums Along at 98
Post Your Comments:
(Date:5/9/2008)...de protection against heart disease ...ay 8 /PRNewswire/ -- Brown rice, a 100 percent who...hful whole grains, according,to an announcement th...,(FDA) that will allow brown rice food labels to b... consumers to easily identify brown rice as a food...
(Date:5/9/2008)...swire-USNewsire/ -- U.S.,corporations providing cr...he Cyclone Nargis in Myanmar are relying upon thei...to ensure that the aid will reach the people,and o...o remember the complete story of the humanitarian,...and organizations that,provide the supplies that w...
(Date:5/9/2008)...mmary: With the recent devastating,cyclone in Myan...g over a,million people homeless, the need for rel...Tucci and Steve Jones have launched the Myanmar,Ch...r humanitarian needs,with hopes of filling the ne... having 1,000 individuals and companies take the M...
(Date:5/9/2008)...ce Matters at Defunct Facility, CARSON, Calif., M..."Leiner" or "the Company") announced today that it...d States Department of Justice to the U.S.,Bankrup...greement would,resolve the previously disclosed in... distribution of certain over-the-counter (OTC) dr...
Breaking Medicine News(10 mins):Health News:FDA Approves Health Claim for Brown Rice 2Health News:FDA Approves Health Claim for Brown Rice 3Health News:FDA Approves Health Claim for Brown Rice 4Health News:FDA Approves Health Claim for Brown Rice 5Health News:Direct Relief's Corporate Partners Key to Aiding Cyclone Victims 2Health News:New Web Site to Raise Awareness for the Myanmar Crisis Has Lofty Goals 2Health News:Leiner Health Products Submits Proposed Agreement with Department of Justice to U.S. Bankruptcy Court for Approval 2
...f Polish nurses who are seeking pay rises remained...day, and warned they would stay put for weeks unle... pitched camp on a grass verge opposite the govern...ne 19, in the wake of a demonstration by 4,500 med...
...an scientists said Monday they had developed new t...diagnosis of diseases such as diabetes. The bios...at the state-run Korea Advanced Institute of Scien... proved that transistors can be used not only for ...
...Lady of the United States, Laura Bush arrived in t... of a four-nation Africa tour to bolster the US go... was met at the airport by President Abdoulaye Wad...m Senegal she is due to travel to nearby Mali then...
...y published on bmj.com today (Tuesday 26 June) que... patients with well-controlled, non-insulin depend...ted today at the American Diabetes Association Con...current guidelines for self-monitoring among these...
Other Medicine News:Health News:Street-protesting Polish Nurses Threaten to Stay Put 2Health News:Questions Over Value of Glucose Monitoring for Non-insulin Using Diabetes Patients 2
(Date:5/8/2008)... Other Data Presentations to Focus on Use of P...o Cannot Tolerate Dual-Antiplatelet Therapy, HONG...p data from both,a randomized pilot study and the ...-engineered R stent, the world,s first pro-healing... at EuroPCR 2008 in Barcelona, Spain., The sympos...
(Date:5/7/2008)... International Study to Evaluate Efficacy and Sa... Cause of Blindness, LEVERKUSEN, Germany, MONTV...RNewswire-FirstCall/ -- Bayer HealthCare AG and Re...ay announced that the first patient,has been dosed...udy in a,development program evaluating VEGF Trap-...
(Date:5/7/2008)... WASHINGTON, May 7 /- ...ecialty biopharmaceutical company, presented,today...ses of pivotal trial,results of INTUNIV, a selecti...tional once-daily medication, which is being evalu...n Deficit Hyperactivity Disorder,(ADHD). The data ...
(Date:5/6/2008)... - Preliminary Phase 1 and 2 Data Expecte... May 6 /- Poniard,Pharmaceu... company focused,on oncology, today announced that...2 clinical trial evaluating picoplatin combination...static colorectal cancer (CRC). Early,data from th...
Breaking Medicine Technology:Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008 2Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 2Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 3Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 4Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 5Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 6Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 2Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 3Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 4Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 5Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 6Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 2Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 3Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 4NPS Pharmaceuticals Announces Results of Tender Offer 1344 1NPS Pharmaceuticals Announces Results of Tender Offer 1344 2NPS Pharmaceuticals Announces Results of Tender Offer 1344 3Alseres Pharmaceuticals Inc to Present at Windhovers Therapeutic Area Partnerships Conference 1341 1Alseres Pharmaceuticals Inc to Present at Windhovers Therapeutic Area Partnerships Conference 1341 2PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 564 1PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 564 2PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 564 3PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 564 4Services for patients with BPD need to be improved say psychiatric nurses 4033 1Services for patients with BPD need to be improved say psychiatric nurses 4033 2Services for patients with BPD need to be improved say psychiatric nurses 4033 3
... /PRNewswire-FirstCall/ --,Tapestry Pharmaceutical...ata at the 2007 American Association for Cancer Re...ngeles, Calif.,Scientists from Tapestry Pharmaceut...,s lead compound, TPI 287, in a poster,presentatio...er and,contributes to antitumor activity in the U2...
...)--Mar 15, 2007 - An alarming study,that appeared ...wed,journal of the American Cancer Society), repor...e-year regimen of the hormonal breast,cancer treat...(1), According to the authors, non-compliance with...ively affect treatment efficacy.,While tamoxifen t...
Other Medicine Technology:Tapestry Pharmaceuticals to Present Data on TPI 287 at the 2007,AACR Annual Meeting 2Tapestry Pharmaceuticals to Present Data on TPI 287 at the 2007,AACR Annual Meeting 3Tapestry Pharmaceuticals to Present Data on TPI 287 at the 2007,AACR Annual Meeting 4One-Third of Patients Discontinue Common Breast Cancer Therapy 2One-Third of Patients Discontinue Common Breast Cancer Therapy 3
... the Human Immunodeficiency Virus (HIV-1) undergoe...response to anti-viral drug treatment. Some of the...istant to the action of these drugs, diminishing t...of mutations in HIV-1 that correlate with drug res...
EIA for Donor Screening. Synthetic peptide Enzyme Immunoassay (EIA) for the detection of antibodies to Human Immunodeficiency Virus Types 1 and/or 2,(HIV-1 and HIV-2) in human serum, plasma or ca
...Test (Reveal Test) is MedMiras flagship rapid HIV ...or plasma against HIV-1 that are produced by the b...is based on MedMiras proprietary flow-through memb...test cartridge containing an immunoreactive test m...
The OraQuick ADVANCE Rapid HIV-1/2 Antibody Test is a single-use, qualitative immunoassay to detect antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in oral fluid, fingers
Medicine Products: